Skip to content

Nautilus Biotechnology, Inc.

NAUT

CIK 0001808805 · Laboratory Analytical Instruments · Nasdaq

  • ARYA Sciences Acquisition Corp III (until 2021-06-08)
← back to feed
Revenue (TTM)
—
Q1 Apr 2026
Net Income (TTM)
−$59.92M
+16.6% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$0.48
+16.1% YoY Q1 Apr 2026
Gross Margin
—
Q1 Apr 2026
Operating Margin
—
Q1 Apr 2026
Net Margin
—
Q1 Apr 2026
Free Cash Flow (TTM)
−$57.9M
Q1 Apr 2026
Cash
$14.63M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
127.08M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings